Literature DB >> 21743862

AUSDRISK - application in general practice.

Kam Cheong Wong1, Anthony M Brown, Stephen C H Li.   

Abstract

BACKGROUND: The Australian Type 2 Diabetes Risk Assessment Tool (AUSDRISK) has been promoted since July 2008. We studied its application rate and the profile of a sample of general practice patients within Central West New South Wales from June to December 2010.
METHODS: Stage one assessed the awareness and application of AUSDRISK among general practitioners and general practice registrars. In stage two, the doctors used AUSDRISK and appropriate blood tests to screen patients aged 25-74 years who had not been previously diagnosed with diabetes.
RESULTS: Seventy-eight doctors (response rate 45.1%) completed the survey. A total of 68.2% of general practice registrars and 23.2% of GPs were aware of AUSDRISK. Among the respondents 14.1% (95% CI: 6-22%) applied AUSDRISK in their usual practice, and 39.1% (95% CI: 31-47%) of the 151 patients had high AUSDRISK scores ≥15. DISCUSSION: Two years after the launch of AUSDRISK, the application rate of AUSDRISK is low. In this patient population, many patients had high AUSDRISK scores.

Entities:  

Mesh:

Year:  2011        PMID: 21743862

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  7 in total

1.  Development and internal validation of the Edmonton Obesity Staging System-2 Risk screening Tool (EOSS-2 Risk Tool) for weight-related health complications: a case-control study in a representative sample of Australian adults with overweight and obesity.

Authors:  Evan Atlantis; James Rufus John; S L Hocking; Kath Peters; Kathryn Williams; Paul Dugdale; P Fahey
Journal:  BMJ Open       Date:  2022-06-22       Impact factor: 3.006

2.  Comparison of two methods for assessing diabetes risk in a pharmacy setting in Australia.

Authors:  Monique F Kilkenny; Roslyn Johnson; Nadine E Andrew; Tara Purvis; Alison Hicks; Stephen Colagiuri; Dominique A Cadilhac
Journal:  BMC Public Health       Date:  2014-11-27       Impact factor: 3.295

3.  Incremental predictive value of screening for anxiety and depression beyond current type 2 diabetes risk models: a prospective cohort study.

Authors:  Evan Atlantis; Shima Ghassem Pour; Federico Girosi
Journal:  BMJ Open       Date:  2018-01-23       Impact factor: 2.692

4.  The clinical utility of the AUSDRISK tool in assessing change in type 2 diabetes risk in overweight/obese volunteers undertaking a healthy lifestyle intervention.

Authors:  Allison Martin; Elizabeth P Neale; Linda C Tapsell
Journal:  Prev Med Rep       Date:  2018-11-30

5.  Clinical usefulness of brief screening tool for activating weight management discussions in primary cARE (AWARE): A nationwide mixed methods pilot study.

Authors:  Evan Atlantis; James Rufus John; Paul Patrick Fahey; Samantha Hocking; Kath Peters
Journal:  PLoS One       Date:  2021-10-28       Impact factor: 3.240

6.  What is the effectiveness of a personalised video story after an online diabetes risk assessment? A Randomised Controlled Trial.

Authors:  Susan L Williams; Quyen To; Corneel Vandelanotte
Journal:  PLoS One       Date:  2022-03-03       Impact factor: 3.240

7.  Factors influencing participant enrolment in a diabetes prevention program in general practice: lessons from the Sydney diabetes prevention program.

Authors:  Rachel A Laws; Philip Vita; Kamalesh Venugopal; Chris Rissel; Daniel Davies; Stephen Colagiuri
Journal:  BMC Public Health       Date:  2012-09-24       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.